Pharmaceutical and Immunological Evaluation of Cholera Toxin A1 Subunit as an Adjuvant of Hepatitis B Vaccine Microneedles
ConclusionsCTA1 is an adjuvant that satisfies both the delivery efficiency and the immunological characteristics required for vaccine microneedles. CTA1 will be used as a potential adjuvant through vaccine microneedles.
Source: Pharmaceutical Research - Category: Drugs & Pharmacology Source Type: research
More News: Allergy & Immunology | Cholera | Drugs & Pharmacology | Hepatitis | Hepatitis B | Hepatitis Vaccine | Skin | Study | Vaccines